These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33647408)

  • 1. Repurposing of camptothecin: An esterase-activatable prodrug delivered by a self-emulsifying formulation that improves efficacy in colorectal cancer.
    Fang T; Ye Z; Chen X; Wang Y; Wan J; Wang H
    Int J Pharm; 2021 Apr; 599():120399. PubMed ID: 33647408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuning the efficacy of esterase-activatable prodrug nanoparticles for the treatment of colorectal malignancies.
    Wang Y; Xie H; Ying K; Xie B; Chen X; Yang B; Jin J; Wan J; Li T; Han W; Fang S; Wang H
    Biomaterials; 2021 Mar; 270():120705. PubMed ID: 33581609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity.
    Liu Y; Piao H; Gao Y; Xu C; Tian Y; Wang L; Liu J; Tang B; Zou M; Cheng G
    Int J Nanomedicine; 2015; 10():2295-311. PubMed ID: 25848251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nanotherapeutic strategy to overcome chemoresistance to irinotecan/7-ethyl-10-hydroxy-camptothecin in colorectal cancer.
    Huang Q; Liu X; Wang H; Liu X; Zhang Q; Li K; Chen Y; Zhu Q; Shen Y; Sui M
    Acta Biomater; 2022 Jan; 137():262-275. PubMed ID: 34718178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel SN38-glucose conjugate for colorectal cancer treatment.
    Zhang R; Luo Y; Du C; Wu L; Wang Y; Chen Y; Li S; Jiang X; Xie Y
    Bioorg Med Chem Lett; 2023 Feb; 81():129128. PubMed ID: 36639036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38.
    Bala V; Rao S; Boyd BJ; Prestidge CA
    J Control Release; 2013 Nov; 172(1):48-61. PubMed ID: 23928356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single protein encapsulated SN38 for tumor-targeting treatment.
    Yu C; Huang F; Wang K; Liu M; Chow WA; Ling X; Li F; Causey JL; Huang X; Cook-Wiens G; Cui X
    J Transl Med; 2023 Dec; 21(1):897. PubMed ID: 38072965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects.
    Du Y; Zhang W; He R; Ismail M; Ling L; Yao C; Fu Z; Li X
    Bioorg Med Chem; 2017 Jun; 25(12):3247-3258. PubMed ID: 28465086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Intratumoral Delivery of SN38 as a Tocopherol Oxyacetate Prodrug Using Nanoparticles in a Neuroblastoma Xenograft Model.
    Nguyen F; Alferiev I; Guan P; Guerrero DT; Kolla V; Moorthy GS; Chorny M; Brodeur GM
    Clin Cancer Res; 2018 Jun; 24(11):2585-2593. PubMed ID: 29514842
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors.
    Nguyen F; Guan P; Guerrero DT; Kolla V; Naraparaju K; Perry LM; Soberman D; Pressly BB; Alferiev IS; Chorny M; Brodeur GM
    Cancer Res; 2020 Oct; 80(19):4258-4265. PubMed ID: 32839252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DTS-108, a novel peptidic prodrug of SN38: in vivo efficacy and toxicokinetic studies.
    Meyer-Losic F; Nicolazzi C; Quinonero J; Ribes F; Michel M; Dubois V; de Coupade C; Boukaissi M; Chéné AS; Tranchant I; Arranz V; Zoubaa I; Fruchart JS; Ravel D; Kearsey J
    Clin Cancer Res; 2008 Apr; 14(7):2145-53. PubMed ID: 18381956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies.
    Zhang H; Wang J; Mao W; Huang J; Wu X; Shen Y; Sui M
    J Control Release; 2013 Mar; 166(2):147-58. PubMed ID: 23266448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors.
    Fang T; Dong Y; Zhang X; Xie K; Lin L; Wang H
    Int J Pharm; 2016 Oct; 512(1):39-48. PubMed ID: 27544846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanoparticles loaded with 7-ethyl-10-hydroxycamptothecin-phospholipid complex: in vitro and in vivo studies.
    Liu H; Lu H; Liao L; Zhang X; Gong T; Zhang Z
    Drug Deliv; 2015; 22(6):701-9. PubMed ID: 24625262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy.
    Xing J; Zhang X; Wang Z; Zhang H; Chen P; Zhou G; Sun C; Gu N; Ji M
    Int J Nanomedicine; 2019; 14():5201-5213. PubMed ID: 31371956
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydrophobized SN38 to redox-hypersensitive nanorods for cancer therapy.
    Zheng Y; Yan X; Wang Y; Duan X; Wang X; Chen C; Tian D; Luo Z; Zhang Z; Zeng Y
    J Mater Chem B; 2019 Jan; 7(2):265-276. PubMed ID: 32254551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug.
    Senter PD; Beam KS; Mixan B; Wahl AF
    Bioconjug Chem; 2001; 12(6):1074-80. PubMed ID: 11716702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of a camptothecin prodrug by specific carboxylesterases as predicted by quantitative structure-activity relationship and molecular docking studies.
    Yoon KJ; Krull EJ; Morton CL; Bornmann WG; Lee RE; Potter PM; Danks MK
    Mol Cancer Ther; 2003 Nov; 2(11):1171-81. PubMed ID: 14617791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy.
    He W; Du Y; Zhou W; Wang T; Li M; Li X
    Eur J Pharm Sci; 2020 Jul; 150():105340. PubMed ID: 32371069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Hydrophilic Camptothecin Derivatives Conjugated to Branched Glycerol Trimer Suppress Tumor Growth without Causing Diarrhea in Murine Xenograft Models of Human Lung Cancer.
    Tsuchihashi Y; Abe S; Miyamoto L; Tsunematsu H; Izumi T; Hatano A; Okuno H; Yamane M; Yasuoka T; Ikeda Y; Tsuchiya K
    Mol Pharm; 2020 Apr; 17(4):1049-1058. PubMed ID: 32068412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.